$7.57
-0.1-1.30%
al cierre: Nov 18, 4:00 PM EST
$7.67
0.11.32%
Pre-comercialización: 4:00 AM EST
El interés corto en Gyre Therapeutics Inc (NASDAQ:GYRE) ha aumentado durante el último período de informe, aumentando en aumento desde 1.50M hasta 1.54M. Esto representa el 7.43% de las acciones disponibles públicamente de la empresa.
Basado en el volumen promedio reciente de 67.09K acciones negociadas por día, tomaría 22.96 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
GYRE | Gyre Therapeutics, Inc. Common | 10/31/2025 | 11/11/2025 | 7.43% | 20,724,678 | 1,540,111 | 67,091 | 22.96 | |
GYRE | Gyre Therapeutics, Inc. Common | 10/15/2025 | 10/24/2025 | 9.87% | 15,218,298 | 1,502,320 | 100,600 | 14.93 | |
GYRE | Gyre Therapeutics, Inc. Common | 09/30/2025 | 10/09/2025 | 10.98% | 15,218,298 | 1,670,982 | 103,331 | 16.17 | |
GYRE | Gyre Therapeutics, Inc. Common | 09/15/2025 | 09/24/2025 | 10.64% | 15,218,298 | 1,618,588 | 101,190 | 16 | |
GYRE | Gyre Therapeutics, Inc. Common | 08/29/2025 | 09/10/2025 | 11.43% | 15,218,298 | 1,739,858 | 93,593 | 18.59 | |
GYRE | Gyre Therapeutics, Inc. Common | 08/15/2025 | 08/26/2025 | 11.65% | 15,218,298 | 1,772,817 | 83,566 | 21.21 | |
GYRE | Gyre Therapeutics, Inc. Common | 07/31/2025 | 08/11/2025 | 12.59% | 14,714,784 | 1,852,217 | 74,675 | 24.8 | |
GYRE | Gyre Therapeutics, Inc. Common | 07/15/2025 | 07/24/2025 | 12.28% | 14,714,784 | 1,806,857 | 110,404 | 16.37 | |
GYRE | Gyre Therapeutics, Inc. Common | 06/30/2025 | 07/10/2025 | 12.26% | 14,714,784 | 1,804,234 | 253,151 | 7.13 | |
GYRE | Gyre Therapeutics, Inc. Common | 06/13/2025 | 06/25/2025 | 9.58% | 14,714,784 | 1,410,123 | 252,961 | 5.57 | |
GYRE | Gyre Therapeutics, Inc. Common | 05/30/2025 | 06/10/2025 | 9.66% | 14,714,784 | 1,421,641 | 546,003 | 2.6 | |
GYRE | Gyre Therapeutics, Inc. Common | 05/15/2025 | 05/27/2025 | 19.82% | 12,492,562 | 2,475,431 | 118,003 | 20.98 | |
GYRE | Gyre Therapeutics, Inc. Common | 04/30/2025 | 05/09/2025 | 13.46% | 17,593,457 | 2,367,978 | 96,432 | 24.56 | |
GYRE | Gyre Therapeutics, Inc. Common | 04/15/2025 | 04/25/2025 | 14.19% | 17,593,457 | 2,496,324 | 209,435 | 11.92 | |
GYRE | Gyre Therapeutics, Inc. Common | 03/31/2025 | 04/09/2025 | 16.45% | 14,513,438 | 2,387,452 | 311,939 | 7.65 | |
GYRE | Gyre Therapeutics, Inc. Common | 03/14/2025 | 03/25/2025 | 10.52% | 14,513,438 | 1,526,887 | 114,907 | 13.29 | |
GYRE | Gyre Therapeutics, Inc. Common | 02/28/2025 | 03/11/2025 | 20.02% | 6,723,268 | 1,346,149 | 59,319 | 22.69 | |
GYRE | Gyre Therapeutics, Inc. Common | 02/14/2025 | 02/26/2025 | 18.66% | 6,723,268 | 1,254,517 | 46,717 | 26.85 | |
GYRE | Gyre Therapeutics, Inc. Common | 01/31/2025 | 02/11/2025 | 18.57% | 6,723,268 | 1,248,253 | 62,409 | 20 | |
GYRE | Gyre Therapeutics, Inc. Common | 01/15/2025 | 01/27/2025 | 18.78% | 6,723,268 | 1,262,551 | 147,330 | 8.57 | |
GYRE | Gyre Therapeutics, Inc. Common | 12/31/2024 | 01/10/2025 | 14.16% | 6,723,268 | 952,311 | 118,545 | 8.03 | |
GYRE | Gyre Therapeutics, Inc. Common | 12/13/2024 | 12/24/2024 | 12.38% | 6,723,268 | 832,149 | 171,877 | 4.84 | |
GYRE | Gyre Therapeutics, Inc. Common | 11/29/2024 | 12/10/2024 | 8.17% | 6,723,268 | 549,379 | 82,102 | 6.69 | |
GYRE | Gyre Therapeutics, Inc. Common | 11/15/2024 | 11/26/2024 | 5.98% | 6,723,268 | 401,743 | 71,314 | 5.63 | |
GYRE | Gyre Therapeutics, Inc. Common | 10/31/2024 | 11/11/2024 | 2.63% | 14,325,180 | 376,581 | 29,283 | 12.86 | |
GYRE | Gyre Therapeutics, Inc. Common | 10/15/2024 | 10/24/2024 | 3.13% | 14,325,180 | 448,696 | 35,355 | 12.69 | |
GYRE | Gyre Therapeutics, Inc. Common | 09/30/2024 | 10/09/2024 | 3.19% | 14,325,180 | 457,298 | 80,808 | 5.66 | |
GYRE | Gyre Therapeutics, Inc. Common | 09/13/2024 | 09/24/2024 | 2.15% | 14,325,180 | 308,405 | 58,665 | 5.26 | |
GYRE | Gyre Therapeutics, Inc. Common | 08/30/2024 | 09/11/2024 | 2.18% | 14,325,180 | 312,978 | 45,125 | 6.94 | |
GYRE | Gyre Therapeutics, Inc. Common | 08/15/2024 | 08/26/2024 | 2.35% | 14,325,180 | 336,469 | 57,321 | 5.87 | |
GYRE | Gyre Therapeutics, Inc. Common | 07/31/2024 | 08/09/2024 | 4.98% | 6,411,112 | 319,343 | 44,794 | 7.13 | |
GYRE | Gyre Therapeutics, Inc. Common | 07/15/2024 | 07/24/2024 | 4.55% | 6,411,112 | 291,517 | 48,637 | 5.99 | |
GYRE | Gyre Therapeutics, Inc. Common | 06/28/2024 | 07/10/2024 | 2.71% | 6,411,112 | 173,599 | 149,215 | 1.16 | |
GYRE | Gyre Therapeutics, Inc. Common | 06/14/2024 | 06/26/2024 | 2.95% | 6,411,112 | 189,075 | 41,718 | 4.53 | |
GYRE | Gyre Therapeutics, Inc. Common | 05/31/2024 | 06/11/2024 | 3.17% | 6,411,112 | 203,275 | 75,395 | 2.7 | |
GYRE | Gyre Therapeutics, Inc. Common | 05/15/2024 | 05/24/2024 | 2.65% | 6,411,112 | 169,640 | 56,070 | 3.03 | |
GYRE | Gyre Therapeutics, Inc. Common | 04/30/2024 | 05/09/2024 | 1.19% | 6,411,112 | 76,070 | 64,871 | 1.17 | |
GYRE | Gyre Therapeutics, Inc. Common | 04/15/2024 | 04/24/2024 | 2.86% | 6,367,668 | 181,868 | 79,177 | 2.3 | |
GYRE | Gyre Therapeutics, Inc. Common | 03/28/2024 | 04/09/2024 | — | — | 121,193 | 52,658 | 2.3 | |
GYRE | Gyre Therapeutics, Inc. Common | 03/15/2024 | 03/26/2024 | — | — | 125,201 | 44,180 | 2.83 | |
GYRE | Gyre Therapeutics, Inc. Common | 02/29/2024 | 03/11/2024 | — | — | 139,690 | 127,932 | 1.09 | |
GYRE | Gyre Therapeutics, Inc. Common | 02/15/2024 | 02/27/2024 | — | — | 156,334 | 96,428 | 1.62 | |
GYRE | Gyre Therapeutics, Inc. Common | 01/31/2024 | 02/09/2024 | — | — | 210,013 | 94,880 | 2.21 | |
GYRE | Gyre Therapeutics, Inc. Common | 01/12/2024 | 01/24/2024 | — | — | 236,139 | 88,696 | 2.66 | |
GYRE | Gyre Therapeutics, Inc. Common | 12/29/2023 | 01/10/2024 | — | — | 305,849 | 77,576 | 3.94 | |
GYRE | Gyre Therapeutics, Inc. Common | 12/15/2023 | 12/27/2023 | — | — | 204,410 | 170,449 | 1.2 | |
GYRE | Gyre Therapeutics, Inc. Common | 11/30/2023 | 12/11/2023 | — | — | 265,535 | 204,537 | 1.3 | |
GYRE | Gyre Therapeutics, Inc. Common | 11/15/2023 | 11/27/2023 | — | — | 48,782 | 41,314 | 1.18 |
En busca de los valores más cortos?